The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes
Clinical Otolaryngology · 2025
DOI: 10.1111/coa.14264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Otolaryngology, 2025. Verfasst von Yongjia Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Meniere Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
The first purpose of this study was to ascertain the distribution of unilateral Ménière's disease (MD) clinical subgroups in China and compare with the population reported in Europe and the United States. The second purpose was to investigate the effectiveness in different clinical phenotypes.
Methods
Participants were categorised into one of five subtypes using a previously reported classification scheme based on cluster analysis. The distribution and clinical characteristics were analysed and compared with the two cohorts reported in Europe and the United States. Participants were followed up to observe the therapeutic effectiveness over a 2‐year period.
Results
A total of 245 patients diagnosed with UMD were enrolled in the study, with 84 of these participants providing complete and detailed follow‐up data. All of the unilateral MD patients were accurately classified: 58.0% were classic MD, 25.7% were delayed MD, 1.2% was familial MD, 12.7% were sporadic MD with migraine and 2.4% were autoimmune MD. Our findings revealed a significant difference in the distribution between this cohort and the European cohort. Follow‐up assessments revealed worse vertigo control rate in the patients with migraine compared to the classical MD (50.0% vs. 82.6%, p = 0.034).
Conclusion
The distribution of unilateral MD subtypes in this Chinese population differs from that in the European population, and the therapeutic effectiveness varies across subtypes in this cohort. Our study highlights the importance of the clinical heterogeneity in unilateral MD, and further studies are needed to identify the optimal interventions for specific subgroups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, China.
- School of Public Health, Xiangnan University, Chenzhou, Hunan, China.
ORCID-Profile: Yongjia Chen, Mengzhu Jiang, Lingyun Mei
Förderung
- The National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Cai, X., Zhang, Y., He, C., Wu, X., Jiang, L., Chen, H., Liu, J., Pang, B., Zhang, S., Chen, A., Jiang, M., Huang, H., Bai, Y., Nie, Z., & Mei, L. (2025). The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes. Clinical Otolaryngology. https://doi.org/10.1111/coa.14264
Vancouver
Chen Y, Cai X, Zhang Y, He C, Wu X, Jiang L, et al. The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes. Clinical Otolaryngology. 2025. doi:10.1111/coa.14264
BibTeX
@article{Chen2025,
author = {Chen, Yongjia and Cai, Xinzhang and Zhang, Yulu and He, Chufeng and Wu, Xuewen and Jiang, Lu and Chen, Hongsheng and Liu, Jing and Pang, Bo and Zhang, Shuai and Chen, Anhai and Jiang, Mengzhu and Huang, Huping and Bai, Yijiang and Nie, Zequn and Mei, Lingyun},
title = {The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes},
journal = {Clinical Otolaryngology},
year = {2025},
doi = {10.1111/coa.14264}
}
EUVIMED